Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review.

Gracieux J, Sanders GD, Pokorney SD, Lopes RD, Thomas K, Al-Khatib SM.

Int J Cardiol. 2014 Dec 20;177(3):990-4. doi: 10.1016/j.ijcard.2014.09.170. Epub 2014 Oct 5. Review.

PMID:
25449512
2.

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].

Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.

3.

Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review.

Earley A, Persson R, Garlitski AC, Balk EM, Uhlig K.

Ann Intern Med. 2014 Jan 21;160(2):111-21. Review.

PMID:
24592496
4.

Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.

Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M; Israeli Working Group on Pacing and Electrophysiology.

Europace. 2014 Aug;16(8):1175-80. doi: 10.1093/europace/euu015. Epub 2014 Feb 19.

5.

Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there?

Al-Khatib SM.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):140-2. doi: 10.1161/CIRCOUTCOMES.111.960658. No abstract available.

6.

Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Gravelin LM, Yuhas J, Remetz M, Radford M, Foley J, Lampert R.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):152-6. doi: 10.1161/CIRCOUTCOMES.110.956987. Epub 2011 Feb 8.

7.

Is what is good for the gander really good for the goose?

Redberg RF.

Arch Intern Med. 2009 Sep 14;169(16):1460-1. doi: 10.1001/archinternmed.2009.261. No abstract available.

PMID:
19752401
8.

Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?

Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA; NCDR.

Am Heart J. 2009 Aug;158(2):224-9. doi: 10.1016/j.ahj.2009.05.018.

PMID:
19619698
9.

Inequitable distribution of implantable cardioverter defibrillators in Ontario.

Udell JA, Juurlink DN, Kopp A, Lee DS, Tu JV, Mamdani MM.

Int J Technol Assess Health Care. 2007 Summer;23(3):354-61.

PMID:
17579939
10.

Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death.

Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH.

Europace. 2006 Dec;8(12):1054-6. Epub 2006 Nov 13.

11.

Disparities in the use of primary prevention and defibrillator therapy among blacks and women.

Gauri AJ, Davis A, Hong T, Burke MC, Knight BP.

Am J Med. 2006 Feb;119(2):167.e17-21.

PMID:
16443424
12.

Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.

Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE; MUSTT Investigators.

J Cardiovasc Electrophysiol. 2004 Sep;15(9):993-8.

PMID:
15363069
13.

Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.

Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA 3rd, Steinman RC, Parides MK.

Am Heart J. 1997 Nov;134(5 Pt 1):787-98.

PMID:
9398090
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk